configurations include 2 with one fenestration, 18 with two fenestrations, 2 with three fenestrations, 5 with a scallop and one fenestration, and 73 with a scallop and two fenestrations. Mean operative time was 224.4 6 72.1 minutes with a blood loss of 508.2 6 561.0 mL. Mean fluoroscopy time was 64.8 6 25.9 minutes with a radiation dose of 966.5 6 652.6 Gy/cm 2 and 116.3 6 41.4 mL iodinated contrast material. There was no difference in operative time, blood loss, or mean fluoroscopy time between the first 50 and last 50 cases. Mean contrast material volume decreased by 14% from 125 mL to 107 mL (P ¼ .02). The 30-day morbidity includes myocardial infarction (2%), arrhythmia (3%), reintubation (2%), gastrointestinal ischemia (3%), and stroke (1%). There were three perioperative deaths due to decompensated cirrhosis, mesenteric ischemia, and cardiopulmonary arrest, respectively. At an average follow-up of 1.0 6 1.0 years, there were no aneurysm-related deaths with four branch stent thromboses (99% patency) and 91% freedom from endoleak. Reintervention was required in 18 patients, most often for branch vessel kinking (4), endoleak (4), mesenteric ischemia (3), access-related complications (3), and stent maldeployment or thrombosis (2).
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Acute and Chronic Renal Dysfunction After Open and Endovascular Abdominal Aortic Aneurysm Repair
Brandon Van Asseldonk, Ahmed J. Elzahabi, Janice Montbriand, Naomi Eisenberg, Graham Roche-Nagle. University of Toronto, Toronto, Ontario, Canada
Objective: Abdominal aortic aneurysms remain an important health problem specifically for men older than 65 years. Distinct aspects of both endovascular aneurysm repair (EVAR) and open repair place patients at risk for renal dysfunction in the short and long term. Kidney injuries increase the risk of postoperative morbidity, mortality, and prolonged hospital stay. This study analyzed the incidence of acute and chronic renal dysfunction as well as contributing factors in patients after abdominal aortic aneurysm repair.
Methods: Retrospective chart review of patients who underwent either open or endovascular repair of abdominal aortic aneurysm at Toronto General Hospital from August 1, 2010, to June 30, 2016, yielded 587 patients from the Vascular Quality Initiative database. Demographics, comorbidities, operative details, and preoperative and follow-up creatinine values were obtained for patients by electronic medical records.
Results: Of the population of patients generated from chart review (n ¼ 587), a total of 521 remained after application of exclusion criteria, which included preoperative dialysis or kidney transplantation, postoperative creatinine values within 90 days of repair, or any absent primary outcome. The open and endovascular repair groups consisted of 149 (28.6%) and 372 (63.4%) patients, respectively. The majority of patients were male (82.7%), and the mean age was 78.8 years in the EVAR group and 71.5 years in the open group (t ¼ 9.9; P < .0002). Group comparison is included in the Methods: All patients with a diagnosis of aortic tumor treated in a single center together with all case reports and reviews available in the literature (through a specific PubMed search with keywords such as malignant and aorta or aortic tumor or sarcoma or angiosarcoma) were analyzed. Tumor primary location, clinical presentation, histologic features, and treatment choice were all examined. Survival at 1 year, 2 years, and 5 years and the possible preoperative and operative predictors of outcome were evaluated by Kaplan-Meier analysis with log-rank test.
Results: In addition to the 5 cases treated in our center, 218 other cases of malignant aortic tumor have been reported in the literature from 1873 to 2017. Overall, the mean age of the patients was 60.1 6 11.9 years, and the male to female ratio was 1.59:1. The mean overall survival from diagnosis was 13.6 6 7.7 months; 1-, 3-, and 5-year survival rates were 35.2% 6 3.7%, 10.9% 6 2.6%, and 6.1% 6 2.2%, respectively (Fig) . Chronic hypertension (P ¼ .03), fever (P ¼ .03), back pain (P ¼ .01), asthenia (P ¼ .04), and signs of peripheral embolization (P ¼ .007) were significant predictors of patients' poor outcome. Histologic subtypes had different impacts on survival with statistical significance (Table) . Compared with other treatment strategies, combined (surgical + medical) therapy had the best impact on the mean survival rate (surgical + medical, 32.5 6 8.2 months; medical, 14.2 6 7.6 months; surgical, 12 6 1.6 months; no treatment, 8.9 6 2.6 months; P ¼ .001). Analyzing an exclusively medical approach, chemotherapy had the best impact on mean survival rate (chemotherapy, 38.2 6 12.2 months; chemotherapy + radiotherapy, 27.6 6 10.6 months; radiotherapy, 20.4 6 6.5 months; and no medical treatment, 11.3 6 1.3 months; P ¼ .005).
Conclusions: Aortic tumors are a malignant pathologic condition with short survival after initial diagnosis. Survival is further diminished in the presence of clinical factors, such as hypertension, fever, back pain, asthenia, and peripheral embolization. Different histologic subtypes can be related to survival. Combined surgical and medical therapy, particularly chemotherapy, has shown the highest survival rate.
Author Disclosures: G. Faggioli: Nothing to disclose; C. Fenelli: Nothing to disclose; A. Freyrie: Nothing to disclose; G. Indelicato: Nothing to disclose; G. Mauro: Cook Medical: Consulting fees (eg, advisory boards); R. Pini: Nothing to disclose; A. Stella: Nothing to disclose; A. Vacirca: Nothing to disclose. Objective: Racial disparities in open aortic aneurysm repair have been well documented, with black patients reported to suffer from inferior outcomes compared with their white counterparts. It is unclear whether these disparities extend to the less invasive thoracic endovascular aortic repair (TEVAR). We therefore sought to examine the outcomes of black vs white patients undergoing TEVAR.
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Racial Disparities in Endovascular Repair of Thoracic Aortic Aneurysm and Dissection
Methods: The Vascular Quality Initiative data set was retrospectively queried to identify all patients who underwent TEVAR from 2010 to 2017. Univariate (c 2 test, t-test) and multivariate methods (logistic regression and Cox regression) were employed to study patient and operative characteristics in different racial groups and the effects of race on postoperative outcomes and long-term survival after TEVAR.
Results: A total of 9147 patients underwent TEVAR. Most of them were white (74.5%). Black patients were younger (61.4 6 15.0 vs 69.1 6 13.4) and more likely to be female (43.6% vs 34.2%; both P < .001; Table I ). Black patients were also more likely to be symptomatic (57% vs 32%) and to Spindle cell sarcoma 7 6 1.1
